You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 21, 2020

Atthachai Homhuan and Kittiya Nopparatrungroj Speak on New Normal in Pharma and Medical Devices

On May 21, Dr. Atthachai Homhuan, manager of regulatory affairs in Tilleke & Gibbins’ Bangkok office, and Kittiya Nopparatrungroj, consultant and licensed pharmacist, will join together to present a webinar cohosted by Tilleke & Gibbins and the Thai Listed Companies Association (TLCA).

Their session, entitled “New Normal in Pharma and Medical Devices: The Impact of COVID-19,” will dive into the responses to the COVID-19 outbreak by the Thai Food and Drug Administration and the Department of Internal Trade, and how government policy may affect the production and distribution of personal protective equipment, medical devices, and pharmaceutical products. Immediately following the webinar, Atthachai and Kittiya will respond to attendee questions through a brief Q&A session.

The webinar, which will be conducted in Thai language, will go live on Thursday, May 21, at 2:00 p.m. If you’re interested in attending, please register for the webinar by sending an email to [email protected].

RELATED INSIGHTS​ 

May 4, 2018
Alan Adcock, partner and deputy director of Tilleke & Gibbins’ intellectual property and regulatory affairs group, Dr. Jakkrit Kuanpoth, of counsel in the firm’s intellectual property group, and Dr. Atthachai Homhuan, manager in the firm’s regulatory affairs group, were recently interviewed by Asia IP  for an article entitled, “Best Feature: The Shape of Pharma,” which covers pharmaceutical patent protection and challenges in the Asian region.